Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
Baraa Nassar, Neurologist, Public Health Facilitator at IFMSA, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Case Reports in Ophthalmology, adding:
“I am pleased to share that our case report has been published in Case Reports in Ophthalmology (Karger Publishers).
Title:Recurrent Cerebral Venous Sinus Thrombosis Presenting with Isolated Visual Symptoms: A Case Report
This report describes a rare presentation of recurrent cerebral venous sinus thrombosis (CVST), where the patient presented with isolated visual symptoms in the absence of the typical neurological findings.
The case highlights the importance of maintaining a high index of suspicion for CVST, even when symptoms appear subtle, to facilitate timely diagnosis and appropriate management.
We hope this publication contributes to greater awareness of this uncommon clinical presentation and supports clinicians in recognizing similar cases, ultimately improving patient outcomes.
I would like to express my sincere gratitude to my co-authors for their collaboration and dedication throughout this work.”
Title: Recurrent Cerebral Venous Sinus Thrombosis Presenting with Isolated Visual Symptoms: A Case Report
Authors: Ayham Slimi, Islam Ghassan Awessat, Baraa Nassar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian